Global pharma leaders, scientists, and innovators will gather in San Francisco from Nov 03–05, 2025, to explore transformative sessions. Gayatri Srinivas CO-IN Symposia +1 512-270-2990 ...
Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for intrathecal delivery of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nvelop Therapeutics, a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today announced that it will ...
RNA interference (RNAi) is making great strides as an indispensable strategy for target-specific knockdown of gene expression. Emerging second-generation technologies represent advances in RNAi design ...
Americans struggle to enjoy reasonable and timely access to health care. While inadequate access predates the ongoing COVID-19 pandemic, the pandemic’s disruption of traditional delivery modalities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback